Miravo Healthcare™ Announces Third Quarter 2021 Results Release Date and Conference Call Details

Rhea-AI Summary

Nuvo Pharmaceuticals Inc. (TSX:MRV; OTCQX:MRVFF), operating as Miravo Healthcare, announced its third-quarter 2021 financial results will be released on November 15, 2021, before market open. A conference call hosted by President & CEO Jesse Ledger is scheduled for the same day at 11:00 a.m. ET. Investors can access the audio webcast and replay through the provided link. Miravo focuses on various therapeutic areas including pain and neurology, and its operations adhere to strict Good Manufacturing Practices.

Positive

• Scheduled release of Q3 2021 financial results indicates ongoing transparency with investors.
• The upcoming conference call provides a platform for direct communication between management and shareholders.

Negative

• None.

MISSISSAUGA, Ontario--(BUSINESS WIRE)-- Nuvo Pharmaceuticals Inc. (TSX:MRV; OTCQX:MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a Canadian focused, healthcare company with global reach and a diversified portfolio of commercial products, today announced it expects to release its third quarter 2021 financial results before markets open on Monday, November 15, 2021.

The Company will subsequently hold a conference call the same day, Monday, November 1, 2021 at 11:00 a.m. ET, hosted by Jesse Ledger, Miravo’s President & Chief Executive Officer and other senior management. A question-and-answer session will follow the corporate update.

CONFERENCE CALL DETAILS

DATE: Monday, November 15, 2021

TIME: 11:00 a.m. ET

DIAL-IN NUMBERS: (289) 536-4777 or 1 (888) 550-2239

The audio webcast and webcast replay can be accessed at:

https://onlinexperiences.com/Launch/QReg/ShowUUID=1E07F0A9-7B64-4D3F-9EAA-D9A1C0CE92B9

About Miravo Healthcare

Miravo is a Canadian focused, healthcare company with global reach and a diversified portfolio of commercial products. The Company targets several therapeutic areas, including pain, allergy, neurology and dermatology. The Company’s strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets. Miravo’s head office is located in Mississauga, Ontario, Canada, the international operations are located in Dublin, Ireland and the Company’s manufacturing facility is located in Varennes, Québec, Canada. The Varennes facility operates in a Good Manufacturing Practices (GMP) environment respecting the U.S, Canada and E.U. GMP regulations and is regularly inspected by Health Canada and the U.S. Food and Drug Administration. For additional information, please visit www.miravohealthcare.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211101005317/en/

Investor Relations

Stefan Eftychiou

905 326 1888 ext 60

stefan@bristolir.com

Source: Nuvo Pharmaceuticals Inc.

FAQ

When will Miravo Healthcare release its Q3 2021 financial results?

Miravo Healthcare will release its Q3 2021 financial results on November 15, 2021.

What time is the Miravo Healthcare conference call?

The conference call is scheduled for 11:00 a.m. ET on November 15, 2021.

How can I access the audio webcast for Miravo Healthcare's conference call?

The audio webcast can be accessed through the link provided in the press release.

Who will host the conference call for Miravo Healthcare?

The conference call will be hosted by Jesse Ledger, President & CEO of Miravo Healthcare.